Annual report pursuant to Section 13 and 15(d)

10. Stockholders' Equity (Tables)

v3.7.0.1
10. Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2016
Equity [Abstract]  
Summary of preferred stock activity
    Series B     Series C     Series D     Series E     Series G     Series H     Total  
    Shares     Amount     Shares     Amount     Shares       Amount     Shares     Amount     Shares     Amount     Shares     Amount     Shares     Amount  
December 31, 2014     5,000     $ 1           $       200,000       $ 20       100,000       10           $           $       305,000     $31  
Conversion of preferred stock into common stock                                     (200,000 )       (20 )     (55,000 )     (6 )                                     (255,000 )   (26)  
Balance at November 2, 2015     5,000       1                                 45,000       4                               50,000     5  
Cancellation of Medytox shares     (5,000 )     (1 )                               (45,000 )     (4 )                                     (50,000 )   (5)  
Issuance of Rennova shares     5,000       50                                         45,000       450                                       50,000     500  
Stock issued for cash, net of offering costs                 9,000       90                                                                 9,000     90  
Balance at December 31, 2015     5,000       50       9,000       90                     45,000       450                               59,000     590  
Conversion of Series C Preferred shares into common stock                     (260 )     (3 )                                                                       (260 )   (3)  
Exchange of Series C Preferred Stock and warrants for Series G Preferred Stock and warrants                     (8,740 )     (87 )                                       13,793       138                       5,053     51  
Conversion of Series G Preferred Stock into common stock                                                                       (5,232 )     (53 )                     (5,232 )   (53)  
Conversion of Series B Preferred shares into common stock     (5,000 )     (50 )                                                                                       (5,000 )   (50)  
Cancellation of Series E Preferred Stock                                                       (45,000 )     (450 )                                     (45,000 )   (450)  
Issuance of Series H Preferred Stock for cash                                                                                       12,350       124       12,350     124  
Redemption of Series G Preferred Stock                                                                       (8,346 )     (83 )                     (8,346 )   (83)  
Conversion of Series H Preferred Stock into common stock                                                                                       (2,331 )     (24 )     (2,331 )   (24)  
Balance at December 31, 2016         $           $             $ –            $       215     $ 2       10,019     $ 100       10,234    $ 102  
Summary of option activity
    Number of options     Weighted-average exercise price     Weighted-average contractual term  
Outstanding at December 31, 2014     263,367     $ 205.97       4.48  
Granted     5,059     $ 292.80          
Expired     (203,373 )   $ 221.13          
CollabRx merger     1,957     $ 1,270.60          
Exercised     (13,654 )   $ 75.00          
Outstanding at December 31, 2015     53,356     $ 231.96       2.90  
Granted     693,287     $ 118.55          
Expired     (4,284 )   $ 28.69          
Forfeit     (33,334 )   $ 21.60          
Outstanding at December 31, 2016     709,025     $ 129.43          
Exercisable at December 31, 2016     635,690     $ 145.84       8.93  

 

Shares approved for issuance at plan inception     2,048,189  
Options granted in 2014     (587,830 )
Options cancelled in 2014     4,096  
Restricted shares issued in 2014     (86,024 )
Balance at December 31, 2014     1,378,431  
Options granted in 2015     (364,578 )
Options cancelled in 2015     92,168  
Plan cancellation     (1,106,021 )
Balance at December 31, 2015      
Schedule of stock option activity by exercise price
Options outstanding     Options vested and exercisable  
Exercise price     Number outstanding     Weighted average remaining contractual life (years)     Weighted average exercise     Aggregate intrinsic value     Number vested     Weighted average exercise     Aggregate intrinsic value  
  $1,270.60       1,957       6.13       $1,270.60     $       1,957       $1,270.60          
  $300.00       166,667       9.50       $300.00               166,667       $300.00          
  $292.24       4,363       8.54       $292.24               4,363       $292.24          
  $183.09       47,037       1.28       $183.09               47,037       $183.09          
  $150.00       166,667       9.50       $150.00               166,667       $150.00          
  $30.00       164,084       9.50       $30.00               147,415       $30.00          
  $9.00       158,250       9.54       $9.00             101,584       $9.00        
          709,025               $129.43     $       635,690       $145.84     $  
Warrant activity
    Number of warrants     Weighted average exercise price  
Balance at December 31, 2014         $  
Warrants issued during the year     215,054     $ 58.13  
Warrants assumed in the Merger     14,899     $ 6.90  
Balance at December 31, 2015     229,953     $ 1.83  
Cashless exercises     (3,079 )   $ 6.90  
Exchange of December 30, 2015 warrants     (215,054 )   $ 58.13  
Exchange Warrants issued     341,651     $ 13.50  
Warrants issued during the period     1,054,176     $ 11.21  
Balance at December 31, 2016     1,407,647     $ 11.70  
Summary of option activity in the Plan
Shares approved for issuance at plan inception     2,048,189  
Options granted in 2014     (587,830 )
Options cancelled in 2014     4,096  
Restricted shares issued in 2014     (86,024 )
Balance at December 31, 2014     1,378,431  
Options granted in 2015     (364,578 )
Options cancelled in 2015     92,168  
Plan cancellation     (1,106,021 )
Balance at December 31, 2015